About Us

A Message from the CEO

I am pleased to welcome you to the official website of Cello Therapeutics.

Cello is a company with a clear vision of what we want to achieve – to help patients fight cancer with breakthrough cellular nanoparticle (CNP) drugs that can minimize the harmful side effects of drugs while curing cancer completely. We believe our CNP platform can solve the cancer problem, one of the greatest health challenges to human.

We will accomplish our mission through experienced leadership, the passion of our employees, and a commitment to excellence. We are not alone in this global effort to battle cancers. We thank you for being an invaluable part of our ongoing success and for your support and contributions – it matters.

Jie Zhang Signature

Jie Zhang
Chief Executive Officer

Dr Jie Zhang

About Our Company

Cello Therapeutics, Inc. (Cello) is a leading biomedical company focused on developing novel nanoparticle delivery platforms for cancer treatment. Our cellular nanoparticles (CNPs) are comprised of three main components—drug payload, biocompatible polymer, and natural cellular membrane. The payload could be a chemotherapy or immunomodulatory agent, mRNA or siRNA. The drugs are loaded within the biodegradable polymer core, which is then coated with membrane derived from human cells. This cell membrane coating technology is a recent breakthrough in the field of nanomedicine. Our target is to treat all types of cancers with a single delivery platform. In vitro and in vivo studies suggest that these biomimetic nanoparticles significantly improve the performance of chemotherapy, immunotherapy, and improve the delivery of mRNA an siRNA to tumor sites. One of our immunotherapy nanoparticle formulations has increased the cancer survival rate to 85-100% in a mouse cancer model in repeated in vivo studies. In animal studies, the delivery of mRNA and siRNA via CNP platform increases efficiency over 10 times and 7 times, respectively.

Founded in 2016 in San Diego, CA, Cello has been committed to saving patients’ lives. We keep cancer patients in our hearts as we relentlessly develop and test new formulations that improve upon current cancer therapies. Our objective is to accelerate the process of delivering novel and effective medical treatments to cancer patients’ hands.

Cello is currently in pre-clinical testing and preparing to file applications to bring our first nanoparticle formulation into human clinical trials in the near future.

Cello Team

Our Team

We pride ourselves on having a diverse and passionate team made up of chemists, biologists, bioengineers, and medical and biomedical scientists. Many of our team members have firsthand experience in the field, and we all share a steadfast belief that communities are the best agents of their own change.